Timea is a Molecular biologist (MSc) & Computational chemist (MSc, PhD), science liaison, and strategic business development and marketing specialist, with 15 years in pharmaceutical R&D, biotech and scientific software development.
Basilea Pharmaceutica and the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, announced they have agreed on the details of Basilea’s ... Read more
New research supported the efficacy of the recombinant human soluble thrombomodulin (rhTM) for the treatment of acute exacerbation (AE) resulting from idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP), but further ... Read more
Basilea Pharmaceutica, Ltd., presented scientific data on its antifungal treatment isavuconazole (Cresemba) and antibiotic ceftobiprole (Zevtera) in a number of poster and oral presentations at the European Congress of Clinical Microbiology and ... Read more
Pin It on Pinterest